[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 1965

Aerosolized Steroids and Induced Cushing's Syndrome

Author Affiliations


From the Department of Medicine, University of California Center for the Health Sciences. Clinical Instructor in Medicine (Dr. Novey); Assistant Professor in Medicine (Dr. Beall).

Arch Intern Med. 1965;115(5):602-605. doi:10.1001/archinte.1960.03860170084018

SHORTLY after the dramatic introduction of the adrenal corticosteroids into clinical medicine in 1949, they were used in the treatment of patients with asthma. The subsequent experiences of many medical observers have been similar. They found that the compounds suppress the signs and symptoms of asthma but do not affect a permanent remission without removal of the underlying causes. This suppression is regularly accompanied by the undesirable sideeffects of Cushing's syndrome. These effects may consist only of facial rounding and erythema, increased facial and neck hair, striae on the lower trunk and thighs, abdominal protrusion, acne, and easy bruising. More serious complications such as hypertension, hyperglycemia, masking of infections, bleeding duodenal ulcers, and osteoporosis with vertebral fractures have been reliably attributed to the steroids.1-4

An effort to minimize these side effects has led to the development of the steroids in a nebulized form. Expectations were for a direct

First Page Preview View Large
First page PDF preview
First page PDF preview